Abstract
Abstract
Background
One strategy to address the high number of U.S. opioid-related deaths is to restrict high-risk or inappropriate opioid analgesic prescribing and dispensing. Federal and state laws and regulations have implemented restrictions but less is known about commercial and public payers’ policies aside from clinician anecdotal reports that these policies are increasing. To assess the number and types of policies with temporal trends, we examined commercial and public (Medicaid) payer policies in one state, Michigan, that has high opioid-related deaths and implemented opioid analgesic prescribing laws.
Methods
Policies for seven large commercial payers and the public payer for 2012–2018 were reviewed and categorized by actions. Joinpoint regression was used to summarize temporal trends on number of policies for all payers and subgroups.
Results
Across the 7 years, there were 529 action policies (75.57 (95% confidence intervals (CI) 35.93, 115.22) actions per year) with a range of 36 to 103 actions by payer. Limitations on number of days for initial prescriptions and prior authorizations were the most frequently implemented policy. The temporal trend showed a decline in new policies from 2012 to 2013 but a steady increase from 2014 to 2018 (average annual percent change or AAPC=29.6% (95% confidence intervals 13.2, 48.5%)). The public payer (n=47 policies) showed no increase in number of policies over time (AAPC=2.9% (95% CI -41.6, 61.6%).
Conclusions
The eight commercial and public payers implemented many new policies to restrict opioid analgesic prescribing with a steady increase in the number of such policies implemented from 2014 to 2018. This case study documented that at least in one state with high opioid-related deaths and multiple commercial payers, new and different policies were increasingly implemented creating barriers to patient care. The impact of these policies is understudied, complicating recommendation of best practices.
Funder
Blue Cross Blue Shield of Michigan Foundation
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Health Policy
Reference41 articles.
1. National Institute on Drug Abuse: National overdose deaths involving prescription opioids-number all ages 1999–2017. 2020. https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates#:~:text=Drug%20overdose%20deaths%20involving%20prescription,of%20deaths%20dropped%20to%2014%2C975. Accessed 13 July 2020.
2. National Institute on Drug Abuse: Decline in national overdose deaths involving prescription opioids from 2017–2018. 2020. https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates#:~:text=Drug%20overdose%20deaths%20involving%20prescription,of%20deaths%20dropped%20to%2014%2C975. Accessed 13 July 2020.
3. Liu Y, Baker O, Schuur JD, Weiner SGL. Effects of rescheduling hydrocodone on opioid orescribing in Ohio. Pain Med. 2019; https://doi.org/10.1093/pm/pnz210.
4. Moyo P, Simoni-Wastila L, Griffin BA, Onukwugha E, Harrington D, Alexander GC, Palumbo F. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US states. Addiction. 2017;112:1784–96 https://doi.org/10.1111/add.13860.
5. Fink DS, Schleimer JP, Sarvet A, Grover KK, Delcher C, Castillo-Carniglia A, Kim J H, Rivera-Aguirre A E, Henry SG, Martins SS, Cerdá M. Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: A ystematic review. Annals of Internal Medicine, 2018168:783–790. https://doi.org/10.7326/M17-3074..
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献